6610-33-9 Usage
Uses
Used in Organic Synthesis:
N-(3,4-Dimethylphenyl)hydrazinecarbothioamide is utilized as a reagent in organic synthesis for its ability to contribute to the formation of various complex organic compounds. Its presence can influence the reactivity and selectivity of reactions, making it a valuable component in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, N-(3,4-Dimethylphenyl)hydrazinecarbothioamide serves as a building block for the development of new pharmaceutical agents. Its unique structure allows it to be a part of the molecular framework of potential drug candidates, contributing to their biological activity and pharmacological properties.
Used in Pharmaceutical Research:
Due to its distinctive chemical features, N-(3,4-Dimethylphenyl)hydrazinecarbothioamide may be explored in pharmaceutical research for its potential to contribute to the discovery and design of novel therapeutic agents. Its incorporation into drug molecules could lead to new treatments for various diseases and medical conditions.
Used in Material Science:
N-(3,4-DIMETHYLPHENYL)HYDRAZINECARBOTHIOAMIDE's properties may also find applications in material science, where it could be employed to develop new materials with specific characteristics. Its use in this field could lead to advancements in areas such as polymer science, nanotechnology, and the creation of functional materials with tailored properties for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 6610-33-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,6,1 and 0 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 6610-33:
(6*6)+(5*6)+(4*1)+(3*0)+(2*3)+(1*3)=79
79 % 10 = 9
So 6610-33-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H13N3S/c1-6-3-4-8(5-7(6)2)11-9(13)12-10/h3-5H,10H2,1-2H3,(H2,11,12,13)
6610-33-9Relevant academic research and scientific papers
Synthesis and biological activities of novel artemisinin derivatives as cysteine protease falcipain-2 inhibitors
Liu, Yang,Lu, Wei-Qiang,Cui, Kun-Qiang,Luo, Wei,Wang, Jian,Guo, Chun
, p. 1525 - 1531 (2013/03/14)
A series of novel artemisinin derivatives were synthesized from artemisinin and different anilines. All compounds were obtained as β-isomers. The target compounds were evaluated for inhibition activity against Plasmodium falciparum falcipain-2 in vitro, and most of them exhibited potent inhibition in the low micromolar range and proved to be new types of falcipain-2 inhibitors.
Synthesis and structure-activity evaluation of isatin-β- thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein
Hall, Matthew D.,Brimacombe, Kyle R.,Varonka, Matthew S.,Pluchino, Kristen M.,Monda, Julie K.,Li, Jiayang,Walsh, Martin J.,Boxer, Matthew B.,Warren, Timothy H.,Fales, Henry M.,Gottesman, Michael M.
experimental part, p. 5878 - 5889 (2011/10/08)
Cancer multidrug resistance (MDR) mediated by ATP-binding cassette (ABC) transporters presents a significant unresolved clinical challenge. One strategy to resolve MDR is to develop compounds that selectively kill cells overexpressing the efflux transport
